A geographical study on amyotrophic lateral sclerosis in Rio Grande Do Norte, Brazil, from 2005 to 2018

References

• van Es MA, Hardiman O, Chio A, Al-Chalabi A, Pasterkamp RJ, Veldink JH, et al. Amyotrophic lateral sclerosis. Lancet. 2017;390:2084–98.
   PubMed Web of Science ®Google Scholar
• Marin B, Boumédiene F, Logroscino G, Couratier P, Babron M-C, Leutenegger AL, et al. Variation in worldwide incidence of amyotrophic lateral sclerosis: a meta-analysis. Int J Epidemiol. 2017;46:57–74.
   PubMed Web of Science ®Google Scholar
• Rechtman L, Jordan H, Wagner L, Horton DK, Kaye W. Racial and ethnic differences among amyotrophic lateral sclerosis cases in the United States. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16:65–71.
   PubMed Web of Science ®Google Scholar
• Marin B, Logroscino G, Boumédiene F, Labrunie A, Couratier P, Babron M-C, et al. Clinical and demographic factors and outcome of amyotrophic lateral sclerosis in relation to population ancestral origin. Eur J Epidemiol. 2016;31:229–45.
   PubMed Web of Science ®Google Scholar
• Chiò A, Traynor BJ. Identifying potential risk factors for developing amyotrophic lateral sclerosis. Neurodegener Dis Manag. 2011;1:463–71.
   Google Scholar
• Olsen SF, Martuzzi M, Elliott P. Cluster analysis and disease mapping: why, when, and how? A step by step guide. Bmj. 1996;313:863–6.
   PubMedGoogle Scholar
• Boumédiène F, Druet-Cabanac M, Marin B, Preux PM, Allée P, Couratier P. Contribution of geolocalisation to neuroepidemiological studies: incidence of ALS and environmental factors in Limousin, France. J Neurol Sci. 2011;309:115–22.
   PubMed Web of Science ®Google Scholar
• Caller TA, Doolin JW, Haney JF, Murby AJ, West KG, Farrar HE, Ball A, et al. A cluster of amyotrophic lateral sclerosis in New Hampshire: a possible role for toxic cyanobacteria blooms. Amyotroph Lateral Scler.2009;10:101–8.
   PubMed Web of Science ®Google Scholar
• Dietrich-Neto F, Callegaro D, Dias-Tosta E, Silva HA, Ferraz ME, Lima JM, et al. Amyotrophic lateral sclerosis in Brazil: 1998 national survey. Arq Neuropsiquiatr. 2000;58:607–15.
   PubMed Web of Science ®Google Scholar
• Moura MC, Casulari LA, Novaes MRCG. Ethnic and demographic incidence of amyotrophic lateral sclerosis (ALS) in Brazil: a population based study. Amyotroph Lateral Scler Frontotemporal Degener. 2016;17:275–81.
   PubMed Web of Science ®Google Scholar
• Couto CM, Queiroz EM, Nogueira R, Küsel APPD, Nascimento OJM. A Brazilian multicentre study on the clinical and epidemiological profiles of 1116 patients with amyotrophic lateral sclerosis and its phenotypic variants. Amyotroph Lateral Scler Frontotemporal Degener. 2022;23:353–362.
   PubMed Web of Science ®Google Scholar
• Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293–9.
   PubMed Web of Science ®Google Scholar
• Cintra VP, Bonadia LC, Andrade HMT, de Albuquerque M, Eusébio MF, de Oliveira DS, et al. The frequency of the C9orf72 expansion in Brazilian population. Neurobiol Aging. 2018;66:179.e1–179.e4.
   PubMed Web of Science ®Google Scholar
• Bailey TC. Spatial statistical methods in health. Cad Saude Publica. 2001;17:1083–98.
   PubMedGoogle Scholar
• Queiroz JW, Dias GH, Nobre ML, De Sousa Dias MC, Araújo SF, Barbosa JD, et al. Geographic information systems and applied spatial statistics are efficient tools to study Hansen's disease (leprosy) and to determine areas of greater risk of disease. Am J Trop Med Hyg. 2010;82:306–14.
   PubMed Web of Science ®Google Scholar
• Lima JMB, Mesquita N, Duro LAA, Furtado AB. Epidemiological aspects of amyotrophic lateral sclerosis in Rio de Janeiro city. Rev Bras Neurol 1983;19:75–8.
   Google Scholar
• Moraes L, Goldbaum M, Silva HCA, Callegaro D. Incidence rate of amyotrophic lateral sclerosis (ALS) in Sao Paulo city, Brazil, 1991-1997. Arq Neuropsiquiatr 1998;56:343.
   Google Scholar
• Longinetti E, Fang F. Epidemiology of amyotrophic lateral sclerosis: an update of recent literature. Curr Opin Neurol. 2019;32:771–6.
   PubMed Web of Science ®Google Scholar
• Luna J, Preux PM, Logroscino G, Erazo D, Del Brutto OH, Boumediene F, et al. Amyotrophic lateral sclerosis mortality rates among ethnic groups in a predominant admixed population in Latin America: a population-based study in Ecuador. Amyotroph Lateral Scler Frontotemporal Degener. 2019;20:404–12.
   PubMed Web of Science ®Google Scholar
• Wagner L, Rechtman L, Jordan H, Ritsick M, Sanchez M, Sorenson E, et al. State, and metropolitan area-based amyotrophic lateral sclerosis (ALS) surveillance. Amyotroph Lateral Scler Frontotemporal Degener. 2015;17:128–34.
   PubMed Web of Science ®Google Scholar
• Pena SD, Bastos-Rodrigues L, Pimenta JR, Bydlowski SP. DNA tests probe the genomic ancestry of Brazilians. Braz J Med Biol Res. 2009;42:870–6.
   PubMed Web of Science ®Google Scholar
• Chadi G, Maximino JR, Jorge FMH, Borba FC, Gilio JM, Callegaro D, Lopes CG, et al. Genetic analysis of patients with familial and sporadic amyotrophic lateral sclerosis in a Brazilian Research Center. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18:249–55.
   PubMed Web of Science ®Google Scholar
• Gonçalves JPN, Leoni TB, Martins MP, Peluzzo TM, Dourado MET Jr, Saute JAM, et al. Genetic epidemiology of familial ALS in Brazil. Neurobiol Aging. 2021;102:227.e1–227.e4.
   PubMed Web of Science ®Google Scholar
• Trilico MLC, Lorenzoni PJ, Kay CSK, Ducci RDP, Fustes OJH, Werneck LC, et al. Characterization of the amyotrophic lateral sclerosis-linked P56S mutation of the VAPB gene in Southern Brazil. Amyotroph Lateral Scler Frontotemporal Degener. 2020;21:286–90.
   PubMed Web of Science ®Google Scholar
• Zaldivar T, Gutierrez J, Lara G, Carbonara M, Logroscino G, Hardiman O. Reduced frequency of ALS in an ethnically mixed population: a population based mortality study. Neurology 2009;72:1640–5.
   PubMed Web of Science ®Google Scholar
• Arthur KC, Calvo A, Price TR, Geiger JT, Chio A, Traynor BJ. Projected increase in amyotrophic lateral sclerosis from 2015 to 2040. Nat Commun. 2016;7:12408.
   PubMed Web of Science ®Google Scholar
• Longinetti E, Regodón Wallin A, Samuelsson K, Press R, Zachau A, Ronnevi LO, et al. The Swedish motor neuron disease quality registry. Amyotroph Lateral Scler Frontotemporal Degener. 2018;19:528–37.
   PubMed Web of Science ®Google Scholar
• Prado LGF, Bicalho IC, Vidigal-Lopes M, Ferreira CJ, Mageste Barbosa LS, Gomez RS, et al. Amyotrophic lateral sclerosis in Brazil: case series and review of the Brazilian literature. Amyotroph Lateral Scler Frontotemporal Degener. 2016;17:282–8.
   PubMed Web of Science ®Google Scholar
• Logroscino G, Marin B, Piccininni M, Arcuti S, Chiò A, Hardiman O, et al. Referral bias in ALS epidemiological studies. PLOS One. 2018;13:e0195821.
   PubMed Web of Science ®Google Scholar
• Logroscino G, Traynor BJ, Hardiman O, Chio' A, Couratier P, Mitchell JD, et al. Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues. J Neurol Neurosurg Psychiatry. 2008;79:6–11.
   PubMed Web of Science ®Google Scholar
• Traynor BJ, Alexander M, Corr B, Frost E, Hardiman O. Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study, 1996–2000. J Neurol Neurosurg Psychiatry. 2003;74:1258–61.
   PubMed Web of Science ®Google Scholar